Status:
ACTIVE_NOT_RECRUITING
Improving Executive Function in Korean Children With Autism
Lead Sponsor:
Korea University
Collaborating Sponsors:
National Research Foundation of Korea
Conditions:
Autism Spectrum Disorder
Eligibility:
All Genders
5-7 years
Phase:
NA
Brief Summary
The purpose of this randomized controlled study is to evaluate the acceptability, feasibility, and preliminary efficacy of an executive function (EF) training intervention for 5- to 7-year-old autisti...
Detailed Description
The ability to self-monitor and flexibly adapt behavior in response to internal or external changes refers to neurocognitive processes known as executive function (EF). EF impairments, such as inflexi...
Eligibility Criteria
Inclusion
- Previous medical diagnosis of ASD, confirmed by Autism Diagnostic Observation Schedule, Second Edition (ADOS-2)
- Non-verbal IQ (NVIQ) equal to or above 85
- Verbal children (with flexible phrases or complex sentences)
Exclusion
- NVIQ below 85
- Presence of medical disorders or injuries with implications for the central nervous system or that require medications that alter EEG processes such as anticonvulsants
- Presence of significant sensory or motor impairment
- Presence of major physical anomalies
Key Trial Info
Start Date :
September 11 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 30 2026
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT06523660
Start Date
September 11 2024
End Date
June 30 2026
Last Update
December 24 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Korea University
Seoul, South Korea